Pyxis Oncology
pyxisoncology.com
Actively hiring
Professional Services
Biotechnology
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$194.5M
2 rounds on record
Latest round
$172.5M
Venture round · Mar 2021 · 5 yr ago
Backers
1
RA Capital Management
The money's age
Long since its last round
67 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 22, 2021
Board appointment Christopher ODonnell, Director · SEC Form D
Mar 5, 2021
Raised a round Venture round $172.5M · SEC Form D
Jun 28, 2019
Raised a round Venture round $22M · SEC Form D
2018
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Mar 2021 | $172.5M | — | SEC Form D |
| Venture round | Jun 2019 | $22M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Pyxis Oncology, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
David SteinbergDirectorSEC Form D
Lara SullivanExecutive Officer, DirectorSEC Form D
Robert CraneExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
RA Capital Management Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Logic gated immunotherapies for cancer and autoimmune disease. Synolo Therapeutics is advancing a new class of therapeutics for cancer.
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse…
PAhR Therapeutics is a clinical-stage biotech company advancing innovative therapies to treat pulmonary arterial hypertension (PAH) through…
Next generation immunotherapies for hard-to-treat cancers that are allogeneic and switchable.
Solstice Oncology is a clinical stage immuno-oncology company developing a therapeutic that meets cancer at its most vulnerable moment…
Unlocking the full potential of chemoproteomics to accelerate the discovery of new small molecules that can change the course of disease.
People
David Steinberg
Director
Lara Sullivan
Executive Officer, Director
Robert Crane
Executive Officer
Christoph Westphal
Director
John Flavin
Director
Lucio Iannone
Director
Geeta Vemuri
Director
Jak Knowles
Director
Christopher ODonnell
Director
Gotham Makker
Director
Christian Schetter
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston
United States
HQ